Pediatrix Medical Group Q2 Revenue USD 487.783 Million Vs. IBES Estimate USD 478.4 Million
MD•Q2 results
Aug. 4 (Reuters) - Pediatrix Medical Group Q2 adjusted EBITDA was USD 76.429 million vs. IBES estimate of USD 75.7 million.
- Q2 income from operations: USD 56.922 million
- Q2 net income: USD 39.843 million
- Q2 operating expenses: USD 430.861 million
Full-year outlook
The company said FY adjusted EBITDA outlook is USD 280 million to USD 300 million, compared with IBES estimate of USD 289.5 million.
